Press Releases

Keep up with our latest news

Optivida Health Contracts with Frelii, Inc for DNA Sequencing Services to Maximize Hemp Extract and CBD Use, Alignment & Understanding by Customers

05-01-19

LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI) (“Frelii” or “The Company”) today announced that it has signed a contract and licensing agreement with Optivida Health (Optivida), one of the nation’s leaders in advanced hemp extract for the consumer market. Optivida will leverage Frelii’s proprietary DNA Kit Packages™ to ensure Optivida customers can realize the optimal benefits of which specific Optivida products best suit their unique DNA profile. Keep Reading

 

Frelii Enters Strategic Agreement to Advance Cutting-edge Genomic Science and Applications

03-20-19

LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI) (“Frelii” or “The Company”) today announced that it has signed a Memorandum of Understanding (MOU) with NewPath Health Care Solutions, Inc. of Ontario, Canada; Mercator Biologic, Inc. of Centerville, Utah; and True DNA Story, LLC of Centerville, Utah. The purpose of the MOU is to strategically explore the full capabilities of each company to identify synergies and opportunities in order to leverage the unique skillsets of the collective. Keep Reading

Frelii Appoints Two New Members to its Scientific Advisory Board

02-14-19

LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI) (“Frelii” or “The Company”) today announced that it has appointed two renowned physicians, Anthony R. Torres, M.D. and Susan H. Morelli M.D., to its Scientific Advisory Board. Keep Reading

Frelii Speaks with Potential Partners at CES about the Future of AI in DNA Sequencing and Analysis

01-11-19

LAS VEGAS–(BUSINESS WIRE)–SPECIAL TO CES—Executives from Frelii Inc. (OTCQB: FRLI) met with potential partners and prospects from industries including medical cannabis, precision medicine, consumer wellness, insurance and hospital systems during the CES conference in Las Vegas, Nevada. The Frelii team discussed recent advancements in artificial intelligence (AI) systems that are fueling an AI-driven revolution in the field of genomics and DNA sequencing. Keep Reading